middle.news
Richter’s A$6.40 Mayne Pharma offer puts US franchises in the spotlight
9:13am on Tuesday 17th of November, 2026 AEDT
•
Pharmaceuticals
Read Story
Richter’s A$6.40 Mayne Pharma offer puts US franchises in the spotlight
9:13am on Tuesday 17th of November, 2026 AEDT
Key Points
A$6.40 cash offer values equity at approximately A$604 million
99.4% premium to Mayne Pharma’s 16 November closing price
Board recommendation backed by shareholders representing 22.14% of shares
Scheme targeted for implementation in mid to late March 2027
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE